145 related articles for article (PubMed ID: 32348623)
1. Thrombospondin-5 and fluvastatin promote angiogenesis and are protective against endothelial cell apoptosis.
Muqri F; Helkin A; Maier KG; Gahtan V
J Cell Biochem; 2020 Oct; 121(10):4154-4165. PubMed ID: 32348623
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1, -2 and -5 have differential effects on vascular smooth muscle cell physiology.
Helkin A; Maier KG; Gahtan V
Biochem Biophys Res Commun; 2015 Sep; 464(4):1022-1027. PubMed ID: 26168731
[TBL] [Abstract][Full Text] [Related]
3. Fluvastatin inhibits intimal hyperplasia in wild-type but not Thbs1-null mice.
Desai P; Helkin A; Odugbesi A; Stein J; Bruch D; Lawler J; Maier KG; Gahtan V
J Surg Res; 2017 Apr; 210():1-7. PubMed ID: 28457315
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of differentiation/DNA binding proteins Id1 and Id3 are regulated by statins in endothelial cells.
Pammer J; Reinisch C; Kaun C; Tschachler E; Wojta J
Endothelium; 2004; 11(3-4):175-80. PubMed ID: 15370294
[TBL] [Abstract][Full Text] [Related]
5. CD36-TSP-HRGP interactions in the regulation of angiogenesis.
Silverstein RL; Febbraio M
Curr Pharm Des; 2007; 13(35):3559-67. PubMed ID: 18220792
[TBL] [Abstract][Full Text] [Related]
6. Thrombospondin-1-induced apoptosis of brain microvascular endothelial cells can be mediated by TNF-R1.
Rege TA; Stewart J; Dranka B; Benveniste EN; Silverstein RL; Gladson CL
J Cell Physiol; 2009 Jan; 218(1):94-103. PubMed ID: 18726995
[TBL] [Abstract][Full Text] [Related]
7. Proangiogenic Properties of Thrombospondin-4.
Muppala S; Frolova E; Xiao R; Krukovets I; Yoon S; Hoppe G; Vasanji A; Plow E; Stenina-Adognravi O
Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):1975-86. PubMed ID: 26139464
[TBL] [Abstract][Full Text] [Related]
8. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
[TBL] [Abstract][Full Text] [Related]
9. Metformin decreases angiogenesis via NF-kappaB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1.
Tan BK; Adya R; Chen J; Farhatullah S; Heutling D; Mitchell D; Lehnert H; Randeva HS
Cardiovasc Res; 2009 Aug; 83(3):566-74. PubMed ID: 19414528
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor signaling pathway in endothelial cells is activated by BMPER to promote angiogenesis.
Esser JS; Rahner S; Deckler M; Bode C; Patterson C; Moser M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):358-67. PubMed ID: 25503991
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondins Differentially Regulate Proteins Involved in Arterial Remodeling.
Kassem MM; Helkin A; Maier KG; Gahtan V
Physiol Res; 2019 Dec; 68(6):893-900. PubMed ID: 31647293
[TBL] [Abstract][Full Text] [Related]
12. Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels.
Shao H; Tan Y; Eton D; Yang Z; Uberti MG; Li S; Schulick A; Yu H
Stem Cells; 2008 May; 26(5):1376-84. PubMed ID: 18308946
[TBL] [Abstract][Full Text] [Related]
13. The proangiogenic phenotype of human tumor-derived endothelial cells depends on thrombospondin-1 downregulation via phosphatidylinositol 3-kinase/Akt pathway.
Bussolati B; Assenzio B; Deregibus MC; Camussi G
J Mol Med (Berl); 2006 Oct; 84(10):852-63. PubMed ID: 16924472
[TBL] [Abstract][Full Text] [Related]
14. An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo.
Noh YH; Matsuda K; Hong YK; Kunstfeld R; Riccardi L; Koch M; Oura H; Dadras SS; Streit M; Detmar M
J Invest Dermatol; 2003 Dec; 121(6):1536-43. PubMed ID: 14675207
[TBL] [Abstract][Full Text] [Related]
15. Fluvastatin reduces oxidative damage in human vascular endothelial cells by upregulating Bcl-2.
Xu SZ; Zhong W; Watson NM; Dickerson E; Wake JD; Lindow SW; Newton CJ; Atkin SL
J Thromb Haemost; 2008 Apr; 6(4):692-700. PubMed ID: 18221360
[TBL] [Abstract][Full Text] [Related]
16. Capillary sprout endothelial cells exhibit a CD36 low phenotype: regulation by shear stress and vascular endothelial growth factor-induced mechanism for attenuating anti-proliferative thrombospondin-1 signaling.
Anderson CR; Hastings NE; Blackman BR; Price RJ
Am J Pathol; 2008 Oct; 173(4):1220-8. PubMed ID: 18772338
[TBL] [Abstract][Full Text] [Related]
17. Thrombospondin-1 modulates the angiogenic phenotype of human cerebral arteriovenous malformation endothelial cells.
Stapleton CJ; Armstrong DL; Zidovetzki R; Liu CY; Giannotta SL; Hofman FM
Neurosurgery; 2011 May; 68(5):1342-53; discussion 1353. PubMed ID: 21307796
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin affects several angiogenic mediators in human endothelial cells.
Dulak J; Loboda A; Jazwa A; Zagorska A; Dörler J; Alber H; Dichtl W; Weidinger F; Frick M; Jozkowicz A
Endothelium; 2005; 12(5-6):233-41. PubMed ID: 16410222
[TBL] [Abstract][Full Text] [Related]
19. Thrombospondin-based antiangiogenic therapy.
Zhang X; Lawler J
Microvasc Res; 2007; 74(2-3):90-9. PubMed ID: 17559888
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin-1 inhibits angiogenesis and promotes follicular atresia in a novel in vitro angiogenesis assay.
Garside SA; Harlow CR; Hillier SG; Fraser HM; Thomas FH
Endocrinology; 2010 Mar; 151(3):1280-9. PubMed ID: 20080874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
